| Date | Upside/Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
|---|---|---|---|---|---|
| 09/18/2023 | 259.28% | HC Wainwright & Co. | → $12 | Reiterates | Buy → Buy |
| 08/29/2023 | 259.28% | HC Wainwright & Co. | → $12 | Reiterates | Buy → Buy |
| 07/28/2023 | 259.28% | HC Wainwright & Co. | → $12 | Reiterates | Buy → Buy |
| 07/12/2023 | 259.28% | HC Wainwright & Co. | → $12 | Reiterates | Buy → Buy |
| 06/19/2023 | 259.28% | HC Wainwright & Co. | → $12 | Reiterates | Buy → Buy |
| 05/23/2023 | 259.28% | HC Wainwright & Co. | → $12 | Reiterates | Buy → Buy |
| 04/18/2023 | 259.28% | HC Wainwright & Co. | → $12 | Reiterates | → Buy |
| 04/18/2023 | 169.46% | Chardan Capital | → $9 | Reiterates | → Buy |
| 03/23/2023 | 259.28% | HC Wainwright & Co. | $11 → $12 | Maintains | Buy |
| 03/22/2023 | 169.46% | Chardan Capital | $8 → $9 | Maintains | Buy |
| 02/28/2023 | 229.34% | HC Wainwright & Co. | → $11 | Reiterates | → Buy |
| 12/23/2022 | 139.52% | Chardan Capital | → $8 | Initiates Coverage On | → Buy |
| 04/12/2021 | 229.34% | HC Wainwright & Co. | → $11 | Initiates Coverage On | → Buy |
| 03/23/2020 | 154.49% | Aegis Capital | → $8.5 | Initiates Coverage On | → Buy |
| 12/30/2019 | 139.52% | B. Riley Securities | $11.25 → $8 | Maintains | Buy |
What is the target price for Anixa Biosciences (ANIX)?
The latest price target for Anixa Biosciences (NASDAQ: ANIX) was reported by HC Wainwright & Co. on September 18, 2023. The analyst firm set a price target for $12.00 expecting ANIX to rise to within 12 months (a possible 259.28% upside). 12 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for Anixa Biosciences (ANIX)?
The latest analyst rating for Anixa Biosciences (NASDAQ: ANIX) was provided by HC Wainwright & Co., and Anixa Biosciences reiterated their buy rating.
When is the next analyst rating going to be posted or updated for Anixa Biosciences (ANIX)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Anixa Biosciences, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Anixa Biosciences was filed on September 18, 2023 so you should expect the next rating to be made available sometime around September 18, 2024.
Is the Analyst Rating Anixa Biosciences (ANIX) correct?
While ratings are subjective and will change, the latest Anixa Biosciences (ANIX) rating was a reiterated with a price target of $0.00 to $12.00. The current price Anixa Biosciences (ANIX) is trading at is $3.34, which is within the analyst's predicted range.